id
stringlengths
15
19
document_id
stringlengths
15
19
passages
list
entities
list
events
list
coreferences
list
relations
list
split_0_train_28400
split_0_train_28400
[ { "id": "split_0_train_28400_passage", "type": "progene_text", "text": [ "Preincubation with wortmannin and LY294002 , two structurally and mechanistically different inhibitors of PI3-K , blocked the VS - mediated increase in MAPK activity and phosphorylation of ERK-1 and ERK-2 ." ], "offsets": [ [ 0, 206 ] ] } ]
[ { "id": "split_0_train_45979_entity", "type": "progene_text", "text": [ "PI3-K" ], "offsets": [ [ 106, 111 ] ], "normalized": [] }, { "id": "split_0_train_45980_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 152, 156 ] ], "normalized": [] }, { "id": "split_0_train_45981_entity", "type": "progene_text", "text": [ "ERK-1" ], "offsets": [ [ 189, 194 ] ], "normalized": [] }, { "id": "split_0_train_45982_entity", "type": "progene_text", "text": [ "ERK-2" ], "offsets": [ [ 199, 204 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28401
split_0_train_28401
[ { "id": "split_0_train_28401_passage", "type": "progene_text", "text": [ "Furthermore , wortmannin inhibited activation of ras , C-raf-1 , and MEK in response to VS ." ], "offsets": [ [ 0, 92 ] ] } ]
[ { "id": "split_0_train_45983_entity", "type": "progene_text", "text": [ "ras" ], "offsets": [ [ 49, 52 ] ], "normalized": [] }, { "id": "split_0_train_45984_entity", "type": "progene_text", "text": [ "C-raf-1" ], "offsets": [ [ 55, 62 ] ], "normalized": [] }, { "id": "split_0_train_45985_entity", "type": "progene_text", "text": [ "MEK" ], "offsets": [ [ 69, 72 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28402
split_0_train_28402
[ { "id": "split_0_train_28402_passage", "type": "progene_text", "text": [ "The addition of a farnesyltransferase inhibitor , B581 , to cells reduced the level of MAPK activation as well as ERK-1 and ERK-2 phosphorylation stimulated by VS ." ], "offsets": [ [ 0, 164 ] ] } ]
[ { "id": "split_0_train_45986_entity", "type": "progene_text", "text": [ "farnesyltransferase" ], "offsets": [ [ 18, 37 ] ], "normalized": [] }, { "id": "split_0_train_45987_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 87, 91 ] ], "normalized": [] }, { "id": "split_0_train_45988_entity", "type": "progene_text", "text": [ "ERK-1" ], "offsets": [ [ 114, 119 ] ], "normalized": [] }, { "id": "split_0_train_45989_entity", "type": "progene_text", "text": [ "ERK-2" ], "offsets": [ [ 124, 129 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28403
split_0_train_28403
[ { "id": "split_0_train_28403_passage", "type": "progene_text", "text": [ "Finally , VS increased PI3-K activity in ras immunoprecipitates ." ], "offsets": [ [ 0, 65 ] ] } ]
[ { "id": "split_0_train_45990_entity", "type": "progene_text", "text": [ "PI3-K" ], "offsets": [ [ 23, 28 ] ], "normalized": [] }, { "id": "split_0_train_45991_entity", "type": "progene_text", "text": [ "ras" ], "offsets": [ [ 41, 44 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28404
split_0_train_28404
[ { "id": "split_0_train_28404_passage", "type": "progene_text", "text": [ "A VS - mediated increase in p70(s6k) activity was also found to be inhibited by wortmannin ." ], "offsets": [ [ 0, 92 ] ] } ]
[ { "id": "split_0_train_45992_entity", "type": "progene_text", "text": [ "p70(s6k)" ], "offsets": [ [ 28, 36 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28405
split_0_train_28405
[ { "id": "split_0_train_28405_passage", "type": "progene_text", "text": [ "Taken together , these results demonstrate that the insulinomimetic effects of VS may be mediated , in part , by PI3 - K - dependent stimulation of the ras - MAPK and p70(s6k) pathways ." ], "offsets": [ [ 0, 186 ] ] } ]
[ { "id": "split_0_train_45993_entity", "type": "progene_text", "text": [ "PI3 - K" ], "offsets": [ [ 113, 120 ] ], "normalized": [] }, { "id": "split_0_train_45994_entity", "type": "progene_text", "text": [ "ras" ], "offsets": [ [ 152, 155 ] ], "normalized": [] }, { "id": "split_0_train_45995_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 158, 162 ] ], "normalized": [] }, { "id": "split_0_train_45996_entity", "type": "progene_text", "text": [ "p70(s6k)" ], "offsets": [ [ 167, 175 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28406
split_0_train_28406
[ { "id": "split_0_train_28406_passage", "type": "progene_text", "text": [ "A phase II trial of DA-125 , a novel anthracycline , in advanced non - small - cell lung cancer ." ], "offsets": [ [ 0, 97 ] ] } ]
[]
[]
[]
[]
split_0_train_28407
split_0_train_28407
[ { "id": "split_0_train_28407_passage", "type": "progene_text", "text": [ "PURPOSE :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_28408
split_0_train_28408
[ { "id": "split_0_train_28408_passage", "type": "progene_text", "text": [ "DA-125 is a novel anthracycline derivative developed by Dong-A Pharmaceutical Company , Korea ." ], "offsets": [ [ 0, 95 ] ] } ]
[]
[]
[]
[]
split_0_train_28409
split_0_train_28409
[ { "id": "split_0_train_28409_passage", "type": "progene_text", "text": [ "Preclinical studies have suggested that DA-125 has greater efficacy and less toxicity than doxorubicin ." ], "offsets": [ [ 0, 104 ] ] } ]
[]
[]
[]
[]
split_0_train_28410
split_0_train_28410
[ { "id": "split_0_train_28410_passage", "type": "progene_text", "text": [ "The maximum tolerable dose has been shown to be 100 mg / m(2 ) in a phase I trial ." ], "offsets": [ [ 0, 83 ] ] } ]
[]
[]
[]
[]
split_0_train_28411
split_0_train_28411
[ { "id": "split_0_train_28411_passage", "type": "progene_text", "text": [ "The purpose of this phase II study was to evaluate the efficacy and toxicity of DA-125 in patients with non - small - cell lung cancer ( NSCLC ) ." ], "offsets": [ [ 0, 146 ] ] } ]
[]
[]
[]
[]
split_0_train_28412
split_0_train_28412
[ { "id": "split_0_train_28412_passage", "type": "progene_text", "text": [ "METHODS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_28413
split_0_train_28413
[ { "id": "split_0_train_28413_passage", "type": "progene_text", "text": [ "Chemotherapy - naive patients with histologically confirmed measurable NSCLC which was not curable by surgery or radiation therapy because of metastasis , local invasion , or recurrence were eligible for this trial ." ], "offsets": [ [ 0, 216 ] ] } ]
[]
[]
[]
[]
split_0_train_28414
split_0_train_28414
[ { "id": "split_0_train_28414_passage", "type": "progene_text", "text": [ "Between May 1996 and April 1997 , 20 patients entered into this trial and were treated with DA-125 administered as a 5 - min intravenous infusion every 3 weeks ." ], "offsets": [ [ 0, 161 ] ] } ]
[]
[]
[]
[]
split_0_train_28415
split_0_train_28415
[ { "id": "split_0_train_28415_passage", "type": "progene_text", "text": [ "The dose of DA-125 was 80 mg / m ( 2 ) during the first cycle , and was adjusted to between 60 and 100 mg / m(2) according to the observed toxicities during subsequent cycles ." ], "offsets": [ [ 0, 176 ] ] } ]
[]
[]
[]
[]
split_0_train_28416
split_0_train_28416
[ { "id": "split_0_train_28416_passage", "type": "progene_text", "text": [ "RESULTS :" ], "offsets": [ [ 0, 9 ] ] } ]
[]
[]
[]
[]
split_0_train_28417
split_0_train_28417
[ { "id": "split_0_train_28417_passage", "type": "progene_text", "text": [ "Among 19 evaluable patients , there was no objective response to DA-125 ." ], "offsets": [ [ 0, 73 ] ] } ]
[]
[]
[]
[]
split_0_train_28418
split_0_train_28418
[ { "id": "split_0_train_28418_passage", "type": "progene_text", "text": [ "Anemia , leukopenia and granulocytopenia of grade 3 or over were observed in 4 % , 6 % and 12 % of chemotherapy cycles , respectively ." ], "offsets": [ [ 0, 135 ] ] } ]
[]
[]
[]
[]
split_0_train_28419
split_0_train_28419
[ { "id": "split_0_train_28419_passage", "type": "progene_text", "text": [ "There were no treatment - related deaths ." ], "offsets": [ [ 0, 42 ] ] } ]
[]
[]
[]
[]
split_0_train_28420
split_0_train_28420
[ { "id": "split_0_train_28420_passage", "type": "progene_text", "text": [ "With regard to nonhematologic toxicities , diarrhea , infection and elevated serum alkaline phosphatase of grade 3 or over were observed in 2 % of cycles , but were tolerable and reversible ." ], "offsets": [ [ 0, 191 ] ] } ]
[ { "id": "split_0_train_45997_entity", "type": "progene_text", "text": [ "alkaline phosphatase" ], "offsets": [ [ 83, 103 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28421
split_0_train_28421
[ { "id": "split_0_train_28421_passage", "type": "progene_text", "text": [ "CONCLUSION :" ], "offsets": [ [ 0, 12 ] ] } ]
[]
[]
[]
[]
split_0_train_28422
split_0_train_28422
[ { "id": "split_0_train_28422_passage", "type": "progene_text", "text": [ "DA-125 at these doses and in this schedule was highly tolerable , but was not active in patients with advanced NSCLC ." ], "offsets": [ [ 0, 118 ] ] } ]
[]
[]
[]
[]
split_0_train_28423
split_0_train_28423
[ { "id": "split_0_train_28423_passage", "type": "progene_text", "text": [ "Factor XI deficiency : literature review and case presentation ." ], "offsets": [ [ 0, 64 ] ] } ]
[ { "id": "split_0_train_45998_entity", "type": "progene_text", "text": [ "Factor XI" ], "offsets": [ [ 0, 9 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28424
split_0_train_28424
[ { "id": "split_0_train_28424_passage", "type": "progene_text", "text": [ "Factor XI deficiency is a rare hereditary bleeding disorder affecting the intrinsic pathway ." ], "offsets": [ [ 0, 93 ] ] } ]
[ { "id": "split_0_train_45999_entity", "type": "progene_text", "text": [ "Factor XI" ], "offsets": [ [ 0, 9 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28425
split_0_train_28425
[ { "id": "split_0_train_28425_passage", "type": "progene_text", "text": [ "Understanding the pathophysiology and clinical significance of this disease entity can help avoid potentially hazardous sequelae ." ], "offsets": [ [ 0, 130 ] ] } ]
[]
[]
[]
[]
split_0_train_28426
split_0_train_28426
[ { "id": "split_0_train_28426_passage", "type": "progene_text", "text": [ "This case presentation discusses laboratory criteria and serum assaying techniques utilized to appropriately manage preoperative or post - traumatic patients suffering from factor XI deficiency ." ], "offsets": [ [ 0, 195 ] ] } ]
[ { "id": "split_0_train_46000_entity", "type": "progene_text", "text": [ "factor XI" ], "offsets": [ [ 173, 182 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28427
split_0_train_28427
[ { "id": "split_0_train_28427_passage", "type": "progene_text", "text": [ "Cardiac looping and the vertebrate left - right axis : antagonism of left - sided Vg1 activity by a right - sided ALK2 - dependent BMP pathway ." ], "offsets": [ [ 0, 144 ] ] } ]
[ { "id": "split_0_train_46001_entity", "type": "progene_text", "text": [ "Vg1" ], "offsets": [ [ 82, 85 ] ], "normalized": [] }, { "id": "split_0_train_46002_entity", "type": "progene_text", "text": [ "ALK2" ], "offsets": [ [ 114, 118 ] ], "normalized": [] }, { "id": "split_0_train_46003_entity", "type": "progene_text", "text": [ "BMP" ], "offsets": [ [ 131, 134 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28428
split_0_train_28428
[ { "id": "split_0_train_28428_passage", "type": "progene_text", "text": [ "The rightward looping of the primary heart tube is dependent upon upstream patterning events that establish the vertebrate left - right axis ." ], "offsets": [ [ 0, 142 ] ] } ]
[]
[]
[]
[]
split_0_train_28429
split_0_train_28429
[ { "id": "split_0_train_28429_passage", "type": "progene_text", "text": [ "In Xenopus , a left - sided Vg1 signaling pathway has been implicated in instructing cells to adopt a ' left - sided identity ' ; however , it is not known whether ' right - sided identity ' is acquired by a default pathway or by antagonism of Vg1 signaling ." ], "offsets": [ [ 0, 259 ] ] } ]
[ { "id": "split_0_train_46004_entity", "type": "progene_text", "text": [ "Vg1" ], "offsets": [ [ 28, 31 ] ], "normalized": [] }, { "id": "split_0_train_46005_entity", "type": "progene_text", "text": [ "Vg1" ], "offsets": [ [ 244, 247 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28430
split_0_train_28430
[ { "id": "split_0_train_28430_passage", "type": "progene_text", "text": [ "Here , we propose that an antagonistic , BMP / ALK2 / Smad - mediated signaling pathway is active on the right side of the Xenopus embryo ." ], "offsets": [ [ 0, 139 ] ] } ]
[ { "id": "split_0_train_46006_entity", "type": "progene_text", "text": [ "BMP" ], "offsets": [ [ 41, 44 ] ], "normalized": [] }, { "id": "split_0_train_46007_entity", "type": "progene_text", "text": [ "ALK2" ], "offsets": [ [ 47, 51 ] ], "normalized": [] }, { "id": "split_0_train_46008_entity", "type": "progene_text", "text": [ "Smad" ], "offsets": [ [ 54, 58 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28431
split_0_train_28431
[ { "id": "split_0_train_28431_passage", "type": "progene_text", "text": [ "Truncated ALK2 receptor expression on the right side of the blastula elicits heart reversals and altered nodal expression ." ], "offsets": [ [ 0, 123 ] ] } ]
[ { "id": "split_0_train_46009_entity", "type": "progene_text", "text": [ "ALK2" ], "offsets": [ [ 10, 14 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28432
split_0_train_28432
[ { "id": "split_0_train_28432_passage", "type": "progene_text", "text": [ "Consistent with these findings , constitutively active ALK2 ( CA - ALK2 ) receptor expression on the left side of the blastula also elicits heart reversals and altered nodal expression ." ], "offsets": [ [ 0, 186 ] ] } ]
[ { "id": "split_0_train_46010_entity", "type": "progene_text", "text": [ "ALK2" ], "offsets": [ [ 55, 59 ] ], "normalized": [] }, { "id": "split_0_train_46011_entity", "type": "progene_text", "text": [ "ALK2" ], "offsets": [ [ 67, 71 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28433
split_0_train_28433
[ { "id": "split_0_train_28433_passage", "type": "progene_text", "text": [ "Coexpression of CA - ALK2 with mature Vg1 ligand results in predominantly left - sided nodal expression patterns and normal heart looping , demonstrating that the ALK2 pathway can 'rescue' left-right reversals that otherwise occur following right - sided misexpression of mature Vg1 ligand alone ." ], "offsets": [ [ 0, 297 ] ] } ]
[ { "id": "split_0_train_46012_entity", "type": "progene_text", "text": [ "ALK2" ], "offsets": [ [ 21, 25 ] ], "normalized": [] }, { "id": "split_0_train_46013_entity", "type": "progene_text", "text": [ "Vg1" ], "offsets": [ [ 38, 41 ] ], "normalized": [] }, { "id": "split_0_train_46014_entity", "type": "progene_text", "text": [ "ALK2" ], "offsets": [ [ 163, 167 ] ], "normalized": [] }, { "id": "split_0_train_46015_entity", "type": "progene_text", "text": [ "Vg1" ], "offsets": [ [ 279, 282 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28434
split_0_train_28434
[ { "id": "split_0_train_28434_passage", "type": "progene_text", "text": [ "Results with chimeric precursor proteins indicate that the mature domain of BMP ligands can mimic the ability of the ALK2 signaling pathway to antagonize the Vg1 pathway ." ], "offsets": [ [ 0, 171 ] ] } ]
[ { "id": "split_0_train_46016_entity", "type": "progene_text", "text": [ "BMP" ], "offsets": [ [ 76, 79 ] ], "normalized": [] }, { "id": "split_0_train_46017_entity", "type": "progene_text", "text": [ "ALK2" ], "offsets": [ [ 117, 121 ] ], "normalized": [] }, { "id": "split_0_train_46018_entity", "type": "progene_text", "text": [ "Vg1" ], "offsets": [ [ 158, 161 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28435
split_0_train_28435
[ { "id": "split_0_train_28435_passage", "type": "progene_text", "text": [ "Consistent with the observed antagonism between BMP and Vg1 ligands , left - sided ectopic expression of Xolloid results in heart reversals ." ], "offsets": [ [ 0, 141 ] ] } ]
[ { "id": "split_0_train_46019_entity", "type": "progene_text", "text": [ "BMP" ], "offsets": [ [ 48, 51 ] ], "normalized": [] }, { "id": "split_0_train_46020_entity", "type": "progene_text", "text": [ "Vg1" ], "offsets": [ [ 56, 59 ] ], "normalized": [] }, { "id": "split_0_train_46021_entity", "type": "progene_text", "text": [ "Xolloid" ], "offsets": [ [ 105, 112 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28436
split_0_train_28436
[ { "id": "split_0_train_28436_passage", "type": "progene_text", "text": [ "Moreover , ectopic expression of Smad1 or Smad7 identified two downstream modulators of the BMP / ALK2 signaling pathway that also can regulate cardiac orientation ." ], "offsets": [ [ 0, 165 ] ] } ]
[ { "id": "split_0_train_46022_entity", "type": "progene_text", "text": [ "Smad1" ], "offsets": [ [ 33, 38 ] ], "normalized": [] }, { "id": "split_0_train_46023_entity", "type": "progene_text", "text": [ "Smad7" ], "offsets": [ [ 42, 47 ] ], "normalized": [] }, { "id": "split_0_train_46024_entity", "type": "progene_text", "text": [ "BMP" ], "offsets": [ [ 92, 95 ] ], "normalized": [] }, { "id": "split_0_train_46025_entity", "type": "progene_text", "text": [ "ALK2" ], "offsets": [ [ 98, 102 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28437
split_0_train_28437
[ { "id": "split_0_train_28437_passage", "type": "progene_text", "text": [ "Collectively , these results define a BMP / ALK2 - mediated pathway on the right side of the Xenopus embryo and , moreover , suggest that left - right patterning preceding cardiac morphogenesis involves the activation of two distinct and antagonistic , left - and right - sided TGF ( beta ) - related signaling pathways ." ], "offsets": [ [ 0, 321 ] ] } ]
[ { "id": "split_0_train_46026_entity", "type": "progene_text", "text": [ "BMP" ], "offsets": [ [ 38, 41 ] ], "normalized": [] }, { "id": "split_0_train_46027_entity", "type": "progene_text", "text": [ "ALK2" ], "offsets": [ [ 44, 48 ] ], "normalized": [] }, { "id": "split_0_train_46028_entity", "type": "progene_text", "text": [ "TGF ( beta )" ], "offsets": [ [ 278, 290 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28438
split_0_train_28438
[ { "id": "split_0_train_28438_passage", "type": "progene_text", "text": [ "Genomic organization of the mouse and human genes encoding the ATP sulfurylase / adenosine 5'-phosphosulfate kinase isoform SK2 ." ], "offsets": [ [ 0, 129 ] ] } ]
[ { "id": "split_0_train_46029_entity", "type": "progene_text", "text": [ "ATP sulfurylase / adenosine 5'-phosphosulfate kinase isoform SK2" ], "offsets": [ [ 63, 127 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28439
split_0_train_28439
[ { "id": "split_0_train_28439_passage", "type": "progene_text", "text": [ "Mammalian ATP sulfurylase / adenosine 5'-phosphosulfate ( APS ) kinase consists of kinase and sulfurylase domains , and catalyzes two sequential reactions to synthesize the universal sulfate donor , phosphoadenosine phosphosulfate ( PAPS ) ." ], "offsets": [ [ 0, 241 ] ] } ]
[ { "id": "split_0_train_46030_entity", "type": "progene_text", "text": [ "ATP sulfurylase / adenosine 5'-phosphosulfate ( APS ) kinase" ], "offsets": [ [ 10, 70 ] ], "normalized": [] }, { "id": "split_0_train_46031_entity", "type": "progene_text", "text": [ "kinase" ], "offsets": [ [ 83, 89 ] ], "normalized": [] }, { "id": "split_0_train_46032_entity", "type": "progene_text", "text": [ "sulfurylase" ], "offsets": [ [ 94, 105 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28440
split_0_train_28440
[ { "id": "split_0_train_28440_passage", "type": "progene_text", "text": [ "In simpler organisms , the ATP sulfurylase and APS kinase reactions are catalyzed by separate enzymes encoded by two or three genes , suggesting that a fusion of separate genes during the course of evolution generated the bifunctional enzyme ." ], "offsets": [ [ 0, 243 ] ] } ]
[ { "id": "split_0_train_46033_entity", "type": "progene_text", "text": [ "ATP sulfurylase" ], "offsets": [ [ 27, 42 ] ], "normalized": [] }, { "id": "split_0_train_46034_entity", "type": "progene_text", "text": [ "APS kinase" ], "offsets": [ [ 47, 57 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28441
split_0_train_28441
[ { "id": "split_0_train_28441_passage", "type": "progene_text", "text": [ "We have characterized the genomic structure of the PAPS synthetase SK2 isoform genes for mouse ( MSK2 ) and human ( HSK2 ) and analyzed the possible fusion region ." ], "offsets": [ [ 0, 164 ] ] } ]
[ { "id": "split_0_train_46035_entity", "type": "progene_text", "text": [ "PAPS synthetase SK2" ], "offsets": [ [ 51, 70 ] ], "normalized": [] }, { "id": "split_0_train_46036_entity", "type": "progene_text", "text": [ "MSK2" ], "offsets": [ [ 97, 101 ] ], "normalized": [] }, { "id": "split_0_train_46037_entity", "type": "progene_text", "text": [ "HSK2" ], "offsets": [ [ 116, 120 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28442
split_0_train_28442
[ { "id": "split_0_train_28442_passage", "type": "progene_text", "text": [ "The MSK2 and HSK2 genes exhibit a common structure of 13 exons , including a 15 - nucleotide alternatively spliced exon 8 ." ], "offsets": [ [ 0, 123 ] ] } ]
[ { "id": "split_0_train_46038_entity", "type": "progene_text", "text": [ "MSK2" ], "offsets": [ [ 4, 8 ] ], "normalized": [] }, { "id": "split_0_train_46039_entity", "type": "progene_text", "text": [ "HSK2" ], "offsets": [ [ 13, 17 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28443
split_0_train_28443
[ { "id": "split_0_train_28443_passage", "type": "progene_text", "text": [ "Enzyme activities of several bacterially expressed exon assemblages showed exons 1 - 6 encode APS kinase , while exons 6 - 13 encode ATP sulfurylase ." ], "offsets": [ [ 0, 150 ] ] } ]
[ { "id": "split_0_train_46040_entity", "type": "progene_text", "text": [ "APS kinase" ], "offsets": [ [ 94, 104 ] ], "normalized": [] }, { "id": "split_0_train_46041_entity", "type": "progene_text", "text": [ "ATP sulfurylase" ], "offsets": [ [ 133, 148 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28444
split_0_train_28444
[ { "id": "split_0_train_28444_passage", "type": "progene_text", "text": [ "The MSK2 construct without the exon 6 - encoded peptide showed no kinase or sulfurylase activity , demonstrating that exon 6 encodes sequences required for both activities ." ], "offsets": [ [ 0, 173 ] ] } ]
[ { "id": "split_0_train_46042_entity", "type": "progene_text", "text": [ "MSK2" ], "offsets": [ [ 4, 8 ] ], "normalized": [] }, { "id": "split_0_train_46043_entity", "type": "progene_text", "text": [ "kinase" ], "offsets": [ [ 66, 72 ] ], "normalized": [] }, { "id": "split_0_train_46044_entity", "type": "progene_text", "text": [ "sulfurylase" ], "offsets": [ [ 76, 87 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28445
split_0_train_28445
[ { "id": "split_0_train_28445_passage", "type": "progene_text", "text": [ "Exon 1 and its 5' - flanking sequence are highly divergent between the two species , and intron 1 of the HSK2 gene contains a region similar to the MSK2 promoter sequence , suggesting that it may be the remnant of a now - superceded regulatory region ." ], "offsets": [ [ 0, 252 ] ] } ]
[ { "id": "split_0_train_46045_entity", "type": "progene_text", "text": [ "HSK2" ], "offsets": [ [ 105, 109 ] ], "normalized": [] }, { "id": "split_0_train_46046_entity", "type": "progene_text", "text": [ "MSK2" ], "offsets": [ [ 148, 152 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28446
split_0_train_28446
[ { "id": "split_0_train_28446_passage", "type": "progene_text", "text": [ "The HSK2 promoter contains a GC - rich region , not present in the mouse promoter , and has few transcription factor binding sites in common with MSK2 ." ], "offsets": [ [ 0, 152 ] ] } ]
[ { "id": "split_0_train_46047_entity", "type": "progene_text", "text": [ "HSK2" ], "offsets": [ [ 4, 8 ] ], "normalized": [] }, { "id": "split_0_train_46048_entity", "type": "progene_text", "text": [ "transcription factor" ], "offsets": [ [ 96, 116 ] ], "normalized": [] }, { "id": "split_0_train_46049_entity", "type": "progene_text", "text": [ "MSK2" ], "offsets": [ [ 146, 150 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28447
split_0_train_28447
[ { "id": "split_0_train_28447_passage", "type": "progene_text", "text": [ "These differences in the two promoter regions suggest that species - specific mechanisms regulate expression of the SK2 isoform ." ], "offsets": [ [ 0, 129 ] ] } ]
[ { "id": "split_0_train_46050_entity", "type": "progene_text", "text": [ "SK2" ], "offsets": [ [ 116, 119 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28448
split_0_train_28448
[ { "id": "split_0_train_28448_passage", "type": "progene_text", "text": [ "Glycosylation and proteolytic processing of 70 kDa C - terminal recombinant polypeptides of Plasmodium falciparum merozoite surface protein 1 expressed in mammalian cells ." ], "offsets": [ [ 0, 172 ] ] } ]
[ { "id": "split_0_train_46051_entity", "type": "progene_text", "text": [ "merozoite surface protein 1" ], "offsets": [ [ 114, 141 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28449
split_0_train_28449
[ { "id": "split_0_train_28449_passage", "type": "progene_text", "text": [ "The cDNAs that encode the 70 kDa C - terminal portion of Plasmodium falciparum merozoite surface protein 1 ( MSP-1 ) , with or without an N - terminal signal peptide sequence and C - terminal glycosylphosphatidylinositol ( GPI ) signal sequence of MSP-1 , were expressed in mammalian cell lines via recombinant vaccinia virus ." ], "offsets": [ [ 0, 327 ] ] } ]
[ { "id": "split_0_train_46052_entity", "type": "progene_text", "text": [ "merozoite surface protein 1" ], "offsets": [ [ 79, 106 ] ], "normalized": [] }, { "id": "split_0_train_46053_entity", "type": "progene_text", "text": [ "MSP-1" ], "offsets": [ [ 109, 114 ] ], "normalized": [] }, { "id": "split_0_train_46054_entity", "type": "progene_text", "text": [ "MSP-1" ], "offsets": [ [ 248, 253 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28450
split_0_train_28450
[ { "id": "split_0_train_28450_passage", "type": "progene_text", "text": [ "The polypeptides were studied with respect to the nature of glycosylation , localization , and proteolytic processing ." ], "offsets": [ [ 0, 119 ] ] } ]
[]
[]
[]
[]
split_0_train_28451
split_0_train_28451
[ { "id": "split_0_train_28451_passage", "type": "progene_text", "text": [ "The polypeptides derived from the cDNAs that contained the N - terminal signal peptide were modified with N - linked high mannose type structures and low levels of O - linked oligosaccharides , whereas the polypeptides from the cDNAs that lacked the signal peptide were not glycosylated ." ], "offsets": [ [ 0, 288 ] ] } ]
[]
[]
[]
[]
split_0_train_28452
split_0_train_28452
[ { "id": "split_0_train_28452_passage", "type": "progene_text", "text": [ "The GPI anchor moiety is either absent or present at a very low level in the polypeptide expressed from the cDNA that contained both the signal peptide and GPI signal sequences ." ], "offsets": [ [ 0, 178 ] ] } ]
[]
[]
[]
[]
split_0_train_28453
split_0_train_28453
[ { "id": "split_0_train_28453_passage", "type": "progene_text", "text": [ "Together , these data establish that whereas the signal peptide of MSP-1 is functional , the GPI anchor signal is either nonfunctional or poorly functional in mammalian cells ." ], "offsets": [ [ 0, 176 ] ] } ]
[ { "id": "split_0_train_46055_entity", "type": "progene_text", "text": [ "MSP-1" ], "offsets": [ [ 67, 72 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28454
split_0_train_28454
[ { "id": "split_0_train_28454_passage", "type": "progene_text", "text": [ "The polypeptides expressed from the cDNAs that contained the signal peptide were proteolytically cleaved at their C - termini , whereas the polypeptides expressed from the cDNAs that lacked the signal peptide were uncleaved ." ], "offsets": [ [ 0, 225 ] ] } ]
[]
[]
[]
[]
split_0_train_28455
split_0_train_28455
[ { "id": "split_0_train_28455_passage", "type": "progene_text", "text": [ "While the polypeptide expressed from the cDNA containing both the signal peptide and GPI anchor signal was truncated by approximately 14 kDa at the C - terminus , the polypeptide derived from the cDNA with only the signal peptide was processed to remove approximately 6 kDa , also from the C-terminus ." ], "offsets": [ [ 0, 302 ] ] } ]
[]
[]
[]
[]
split_0_train_28456
split_0_train_28456
[ { "id": "split_0_train_28456_passage", "type": "progene_text", "text": [ "Furthermore , the polypeptides derived from cDNAs that lacked the signal peptide were exclusively localized intra - cellularly , the polypeptides from cDNAs that contained the signal peptide were predominantly intracellular , with low levels on the cell surface ; none of the polypeptides was secreted into the culture medium to a detectable level.These results suggest that N - glycosylation alone is not sufficient for the efficient extracellular transport of the recombinant MSP-1 polypeptides through the secretory pathway in mammalian cells ." ], "offsets": [ [ 0, 547 ] ] } ]
[ { "id": "split_0_train_46056_entity", "type": "progene_text", "text": [ "MSP-1" ], "offsets": [ [ 478, 483 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28457
split_0_train_28457
[ { "id": "split_0_train_28457_passage", "type": "progene_text", "text": [ "Human CD8 beta , but not mouse CD8 beta , can be expressed in the absence of CD8 alpha as a beta beta homodimer ." ], "offsets": [ [ 0, 113 ] ] } ]
[ { "id": "split_0_train_46057_entity", "type": "progene_text", "text": [ "CD8 beta" ], "offsets": [ [ 6, 14 ] ], "normalized": [] }, { "id": "split_0_train_46058_entity", "type": "progene_text", "text": [ "CD8 beta" ], "offsets": [ [ 31, 39 ] ], "normalized": [] }, { "id": "split_0_train_46059_entity", "type": "progene_text", "text": [ "CD8 alpha" ], "offsets": [ [ 77, 86 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28458
split_0_train_28458
[ { "id": "split_0_train_28458_passage", "type": "progene_text", "text": [ "The T cell coreceptor CD8 exists on mature T cells as disulfide - linked homodimers of CD8 alpha polypeptide chains and heterodimers of CD8 alpha - and CD8 beta - chains ." ], "offsets": [ [ 0, 171 ] ] } ]
[ { "id": "split_0_train_46060_entity", "type": "progene_text", "text": [ "CD8" ], "offsets": [ [ 22, 25 ] ], "normalized": [] }, { "id": "split_0_train_46061_entity", "type": "progene_text", "text": [ "CD8 alpha" ], "offsets": [ [ 87, 96 ] ], "normalized": [] }, { "id": "split_0_train_46062_entity", "type": "progene_text", "text": [ "CD8 alpha" ], "offsets": [ [ 136, 145 ] ], "normalized": [] }, { "id": "split_0_train_46063_entity", "type": "progene_text", "text": [ "CD8 beta" ], "offsets": [ [ 152, 160 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28459
split_0_train_28459
[ { "id": "split_0_train_28459_passage", "type": "progene_text", "text": [ "The function of the CD8 alpha - chain for binding to MHC class I and associating with the tyrosine kinase p56lck was demonstrated with CD8 alpha alpha homodimers ." ], "offsets": [ [ 0, 163 ] ] } ]
[ { "id": "split_0_train_46064_entity", "type": "progene_text", "text": [ "CD8 alpha" ], "offsets": [ [ 20, 29 ] ], "normalized": [] }, { "id": "split_0_train_46065_entity", "type": "progene_text", "text": [ "MHC class I" ], "offsets": [ [ 53, 64 ] ], "normalized": [] }, { "id": "split_0_train_46066_entity", "type": "progene_text", "text": [ "tyrosine kinase" ], "offsets": [ [ 90, 105 ] ], "normalized": [] }, { "id": "split_0_train_46067_entity", "type": "progene_text", "text": [ "p56lck" ], "offsets": [ [ 106, 112 ] ], "normalized": [] }, { "id": "split_0_train_46068_entity", "type": "progene_text", "text": [ "CD8 alpha" ], "offsets": [ [ 135, 144 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28460
split_0_train_28460
[ { "id": "split_0_train_28460_passage", "type": "progene_text", "text": [ "CD8 alpha beta functions as a better coreceptor , but the actual function of CD8 beta is less clear ." ], "offsets": [ [ 0, 101 ] ] } ]
[ { "id": "split_0_train_46069_entity", "type": "progene_text", "text": [ "CD8 alpha beta" ], "offsets": [ [ 0, 14 ] ], "normalized": [] }, { "id": "split_0_train_46070_entity", "type": "progene_text", "text": [ "CD8 beta" ], "offsets": [ [ 77, 85 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28461
split_0_train_28461
[ { "id": "split_0_train_28461_passage", "type": "progene_text", "text": [ "Addressing this issue has been hampered by the apparent inability of CD8 beta to be expressed without CD8 alpha ." ], "offsets": [ [ 0, 113 ] ] } ]
[ { "id": "split_0_train_46071_entity", "type": "progene_text", "text": [ "CD8 beta" ], "offsets": [ [ 69, 77 ] ], "normalized": [] }, { "id": "split_0_train_46072_entity", "type": "progene_text", "text": [ "CD8 alpha" ], "offsets": [ [ 102, 111 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28462
split_0_train_28462
[ { "id": "split_0_train_28462_passage", "type": "progene_text", "text": [ "This study demonstrates that human , but not mouse , CD8 beta can be expressed on the cell surface without CD8 alpha in both transfected COS-7 cells and murine lymphocytes ." ], "offsets": [ [ 0, 173 ] ] } ]
[ { "id": "split_0_train_46073_entity", "type": "progene_text", "text": [ "CD8 beta" ], "offsets": [ [ 53, 61 ] ], "normalized": [] }, { "id": "split_0_train_46074_entity", "type": "progene_text", "text": [ "CD8 alpha" ], "offsets": [ [ 107, 116 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28463
split_0_train_28463
[ { "id": "split_0_train_28463_passage", "type": "progene_text", "text": [ "By creating chimeric proteins , we show that the murine Ig domain of CD8 beta is responsible for the lack of expression of murine CD8 beta beta dimers ." ], "offsets": [ [ 0, 152 ] ] } ]
[ { "id": "split_0_train_46075_entity", "type": "progene_text", "text": [ "Ig" ], "offsets": [ [ 56, 58 ] ], "normalized": [] }, { "id": "split_0_train_46076_entity", "type": "progene_text", "text": [ "CD8 beta" ], "offsets": [ [ 69, 77 ] ], "normalized": [] }, { "id": "split_0_train_46077_entity", "type": "progene_text", "text": [ "CD8 beta" ], "offsets": [ [ 130, 138 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28464
split_0_train_28464
[ { "id": "split_0_train_28464_passage", "type": "progene_text", "text": [ "In contrast to CD8 alpha alpha , CD8 beta beta is unable to bind MHC class I in a cell - cell adhesion assay ." ], "offsets": [ [ 0, 110 ] ] } ]
[ { "id": "split_0_train_46078_entity", "type": "progene_text", "text": [ "CD8 alpha" ], "offsets": [ [ 15, 24 ] ], "normalized": [] }, { "id": "split_0_train_46079_entity", "type": "progene_text", "text": [ "CD8 beta" ], "offsets": [ [ 33, 41 ] ], "normalized": [] }, { "id": "split_0_train_46080_entity", "type": "progene_text", "text": [ "MHC class I" ], "offsets": [ [ 65, 76 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28465
split_0_train_28465
[ { "id": "split_0_train_28465_passage", "type": "progene_text", "text": [ "Detection of this form of CD8 should facilitate studies on the function of the CD8 beta - chain and indicates that caution should be used when interpreting studies on CD8 function using chimeric protein with the murine CD8 beta beta Ig domain ." ], "offsets": [ [ 0, 244 ] ] } ]
[ { "id": "split_0_train_46081_entity", "type": "progene_text", "text": [ "CD8" ], "offsets": [ [ 26, 29 ] ], "normalized": [] }, { "id": "split_0_train_46082_entity", "type": "progene_text", "text": [ "CD8 beta" ], "offsets": [ [ 79, 87 ] ], "normalized": [] }, { "id": "split_0_train_46083_entity", "type": "progene_text", "text": [ "CD8" ], "offsets": [ [ 167, 170 ] ], "normalized": [] }, { "id": "split_0_train_46084_entity", "type": "progene_text", "text": [ "CD8 beta" ], "offsets": [ [ 219, 227 ] ], "normalized": [] }, { "id": "split_0_train_46085_entity", "type": "progene_text", "text": [ "Ig" ], "offsets": [ [ 233, 235 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28466
split_0_train_28466
[ { "id": "split_0_train_28466_passage", "type": "progene_text", "text": [ "In addition , we demonstrate that the Ig domains of CD8 alpha are also involved in controlling the ability of CD8 to be expressed ." ], "offsets": [ [ 0, 131 ] ] } ]
[ { "id": "split_0_train_46086_entity", "type": "progene_text", "text": [ "Ig" ], "offsets": [ [ 38, 40 ] ], "normalized": [] }, { "id": "split_0_train_46087_entity", "type": "progene_text", "text": [ "CD8 alpha" ], "offsets": [ [ 52, 61 ] ], "normalized": [] }, { "id": "split_0_train_46088_entity", "type": "progene_text", "text": [ "CD8" ], "offsets": [ [ 110, 113 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28467
split_0_train_28467
[ { "id": "split_0_train_28467_passage", "type": "progene_text", "text": [ "Mutation of B - and F - strand cysteine residues in CD8 alpha reduced the ability of the protein to fold properly and , therefore , to be expressed ." ], "offsets": [ [ 0, 149 ] ] } ]
[ { "id": "split_0_train_46089_entity", "type": "progene_text", "text": [ "CD8 alpha" ], "offsets": [ [ 52, 61 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28468
split_0_train_28468
[ { "id": "split_0_train_28468_passage", "type": "progene_text", "text": [ "Endothelin - dependent and - independent components of strain - activated brain natriuretic peptide gene transcription require extracellular signal regulated kinase and p38 mitogen - activated protein kinase ." ], "offsets": [ [ 0, 209 ] ] } ]
[ { "id": "split_0_train_46090_entity", "type": "progene_text", "text": [ "Endothelin" ], "offsets": [ [ 0, 10 ] ], "normalized": [] }, { "id": "split_0_train_46091_entity", "type": "progene_text", "text": [ "brain natriuretic peptide" ], "offsets": [ [ 74, 99 ] ], "normalized": [] }, { "id": "split_0_train_46092_entity", "type": "progene_text", "text": [ "extracellular signal regulated kinase" ], "offsets": [ [ 127, 164 ] ], "normalized": [] }, { "id": "split_0_train_46093_entity", "type": "progene_text", "text": [ "p38 mitogen - activated protein kinase" ], "offsets": [ [ 169, 207 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28469
split_0_train_28469
[ { "id": "split_0_train_28469_passage", "type": "progene_text", "text": [ "The application of mechanical strain to cultured cardiac myocytes in vitro leads to activation of the brain natriuretic peptide ( BNP ) gene promoter , a marker of cardiac hypertrophy ." ], "offsets": [ [ 0, 185 ] ] } ]
[ { "id": "split_0_train_46094_entity", "type": "progene_text", "text": [ "brain natriuretic peptide" ], "offsets": [ [ 102, 127 ] ], "normalized": [] }, { "id": "split_0_train_46095_entity", "type": "progene_text", "text": [ "BNP" ], "offsets": [ [ 130, 133 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28470
split_0_train_28470
[ { "id": "split_0_train_28470_passage", "type": "progene_text", "text": [ "We have previously shown that this activation results from both a direct mechanostimulatory event and an indirect autocrine / paracrine stimulation involving the sequential production of angiotensin II and endothelin ( ET ) ." ], "offsets": [ [ 0, 225 ] ] } ]
[ { "id": "split_0_train_46096_entity", "type": "progene_text", "text": [ "angiotensin II" ], "offsets": [ [ 187, 201 ] ], "normalized": [] }, { "id": "split_0_train_46097_entity", "type": "progene_text", "text": [ "endothelin" ], "offsets": [ [ 206, 216 ] ], "normalized": [] }, { "id": "split_0_train_46098_entity", "type": "progene_text", "text": [ "ET" ], "offsets": [ [ 219, 221 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28471
split_0_train_28471
[ { "id": "split_0_train_28471_passage", "type": "progene_text", "text": [ "In the present study , we examined the role of p38 mitogen - activated protein kinase ( MAPK ) and extracellular signal regulated kinase ( ERK ) in signaling the increase in promoter activity trafficking through each of these pathways ." ], "offsets": [ [ 0, 236 ] ] } ]
[ { "id": "split_0_train_46099_entity", "type": "progene_text", "text": [ "p38 mitogen - activated protein kinase" ], "offsets": [ [ 47, 85 ] ], "normalized": [] }, { "id": "split_0_train_46100_entity", "type": "progene_text", "text": [ "MAPK" ], "offsets": [ [ 88, 92 ] ], "normalized": [] }, { "id": "split_0_train_46101_entity", "type": "progene_text", "text": [ "extracellular signal regulated kinase" ], "offsets": [ [ 99, 136 ] ], "normalized": [] }, { "id": "split_0_train_46102_entity", "type": "progene_text", "text": [ "ERK" ], "offsets": [ [ 139, 142 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28472
split_0_train_28472
[ { "id": "split_0_train_28472_passage", "type": "progene_text", "text": [ "ET was shown to stimulate both p38 MAPK and ERK activity in these cultures and to activate human BNP ( hBNP ) promoter activity ." ], "offsets": [ [ 0, 129 ] ] } ]
[ { "id": "split_0_train_46103_entity", "type": "progene_text", "text": [ "ET" ], "offsets": [ [ 0, 2 ] ], "normalized": [] }, { "id": "split_0_train_46104_entity", "type": "progene_text", "text": [ "p38 MAPK" ], "offsets": [ [ 31, 39 ] ], "normalized": [] }, { "id": "split_0_train_46105_entity", "type": "progene_text", "text": [ "ERK" ], "offsets": [ [ 44, 47 ] ], "normalized": [] }, { "id": "split_0_train_46106_entity", "type": "progene_text", "text": [ "BNP" ], "offsets": [ [ 97, 100 ] ], "normalized": [] }, { "id": "split_0_train_46107_entity", "type": "progene_text", "text": [ "hBNP" ], "offsets": [ [ 103, 107 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28473
split_0_train_28473
[ { "id": "split_0_train_28473_passage", "type": "progene_text", "text": [ "Activation of the promoter was inhibited approximately 45 % by SB - 203580 , a p38 MAPK inhibitor , and approximately 70 % by PD98059 , an inhibitor of the ERK - activating kinase MAPK kinase ." ], "offsets": [ [ 0, 193 ] ] } ]
[ { "id": "split_0_train_46108_entity", "type": "progene_text", "text": [ "p38 MAPK" ], "offsets": [ [ 79, 87 ] ], "normalized": [] }, { "id": "split_0_train_46109_entity", "type": "progene_text", "text": [ "ERK - activating kinase" ], "offsets": [ [ 156, 179 ] ], "normalized": [] }, { "id": "split_0_train_46110_entity", "type": "progene_text", "text": [ "MAPK kinase" ], "offsets": [ [ 180, 191 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28474
split_0_train_28474
[ { "id": "split_0_train_28474_passage", "type": "progene_text", "text": [ "The ET - independent ( ie , direct ) stimulation of the hBNP promoter by mechanical strain was inhibited approximately 70 % by SB - 203580 and approximately 60 % by PD98059 , implying that similar signaling circuitry is used , albeit to different degrees , by the direct and indirect pathways ." ], "offsets": [ [ 0, 294 ] ] } ]
[ { "id": "split_0_train_46111_entity", "type": "progene_text", "text": [ "ET" ], "offsets": [ [ 4, 6 ] ], "normalized": [] }, { "id": "split_0_train_46112_entity", "type": "progene_text", "text": [ "hBNP" ], "offsets": [ [ 56, 60 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28475
split_0_train_28475
[ { "id": "split_0_train_28475_passage", "type": "progene_text", "text": [ "The p38 MAPK component of both the ET - dependent and the ET - independent responses to strain appears to operate through a series of nuclear factor - kappaB binding , shear stress response element - like structures in the hBNP gene promoter ." ], "offsets": [ [ 0, 243 ] ] } ]
[ { "id": "split_0_train_46113_entity", "type": "progene_text", "text": [ "p38 MAPK" ], "offsets": [ [ 4, 12 ] ], "normalized": [] }, { "id": "split_0_train_46114_entity", "type": "progene_text", "text": [ "ET" ], "offsets": [ [ 35, 37 ] ], "normalized": [] }, { "id": "split_0_train_46115_entity", "type": "progene_text", "text": [ "ET" ], "offsets": [ [ 58, 60 ] ], "normalized": [] }, { "id": "split_0_train_46116_entity", "type": "progene_text", "text": [ "nuclear factor - kappaB" ], "offsets": [ [ 134, 157 ] ], "normalized": [] }, { "id": "split_0_train_46117_entity", "type": "progene_text", "text": [ "hBNP" ], "offsets": [ [ 223, 227 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28476
split_0_train_28476
[ { "id": "split_0_train_28476_passage", "type": "progene_text", "text": [ "Collectively , these data suggest that activation of the BNP promoter by hypertrophic stimuli involves the participation of several independent signaling pathways ." ], "offsets": [ [ 0, 164 ] ] } ]
[ { "id": "split_0_train_46118_entity", "type": "progene_text", "text": [ "BNP" ], "offsets": [ [ 57, 60 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28477
split_0_train_28477
[ { "id": "split_0_train_28477_passage", "type": "progene_text", "text": [ "Such redundancy would help to guarantee generation of the full hypertrophic phenotype independently of the nature of the hypertrophic stimulus ." ], "offsets": [ [ 0, 144 ] ] } ]
[]
[]
[]
[]
split_0_train_28478
split_0_train_28478
[ { "id": "split_0_train_28478_passage", "type": "progene_text", "text": [ "Development of catechol 2,3-dioxygenase - specific primers for monitoring bioremediation by competitive quantitative PCR ." ], "offsets": [ [ 0, 122 ] ] } ]
[ { "id": "split_0_train_46119_entity", "type": "progene_text", "text": [ "catechol 2,3-dioxygenase" ], "offsets": [ [ 15, 39 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28479
split_0_train_28479
[ { "id": "split_0_train_28479_passage", "type": "progene_text", "text": [ "Benzene , toluene , xylenes , phenol , naphthalene , and biphenyl are among a group of compounds that have at least one reported pathway for biodegradation involving catechol 2,3-dioxygenase enzymes ." ], "offsets": [ [ 0, 200 ] ] } ]
[ { "id": "split_0_train_46120_entity", "type": "progene_text", "text": [ "catechol 2,3-dioxygenase" ], "offsets": [ [ 166, 190 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28480
split_0_train_28480
[ { "id": "split_0_train_28480_passage", "type": "progene_text", "text": [ "Thus , detection of the corresponding catechol 2,3-dioxygenase genes can serve as a basis for identifying and quantifying bacteria that have these catabolic abilities ." ], "offsets": [ [ 0, 168 ] ] } ]
[ { "id": "split_0_train_46121_entity", "type": "progene_text", "text": [ "catechol 2,3-dioxygenase" ], "offsets": [ [ 38, 62 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28481
split_0_train_28481
[ { "id": "split_0_train_28481_passage", "type": "progene_text", "text": [ "Primers that can successfully amplify a 238 - bp catechol 2,3-dioxygenase gene fragment from eight different bacteria are described ." ], "offsets": [ [ 0, 133 ] ] } ]
[ { "id": "split_0_train_46122_entity", "type": "progene_text", "text": [ "catechol 2,3-dioxygenase" ], "offsets": [ [ 49, 73 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28482
split_0_train_28482
[ { "id": "split_0_train_28482_passage", "type": "progene_text", "text": [ "The identities of the amplicons were confirmed by hybridization with a 238 - bp catechol 2,3-dioxygenase probe ." ], "offsets": [ [ 0, 112 ] ] } ]
[ { "id": "split_0_train_46123_entity", "type": "progene_text", "text": [ "catechol 2,3-dioxygenase" ], "offsets": [ [ 80, 104 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28483
split_0_train_28483
[ { "id": "split_0_train_28483_passage", "type": "progene_text", "text": [ "The detection limit was 10(2) to 10(3) gene copies , which was lowered to 10 ( 0 ) to 10(1) gene copies by hybridization ." ], "offsets": [ [ 0, 122 ] ] } ]
[]
[]
[]
[]
split_0_train_28484
split_0_train_28484
[ { "id": "split_0_train_28484_passage", "type": "progene_text", "text": [ "Using the dioxygenase - specific primers , an increase in catechol 2 , 3-dioxygenase genes was detected in petroleum - amended soils ." ], "offsets": [ [ 0, 134 ] ] } ]
[ { "id": "split_0_train_46124_entity", "type": "progene_text", "text": [ "dioxygenase" ], "offsets": [ [ 10, 21 ] ], "normalized": [] }, { "id": "split_0_train_46125_entity", "type": "progene_text", "text": [ "catechol 2 , 3-dioxygenase" ], "offsets": [ [ 58, 84 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28485
split_0_train_28485
[ { "id": "split_0_train_28485_passage", "type": "progene_text", "text": [ "The dioxygenase genes were enumerated by competitive quantitative PCR with a 163 - bp competitor that was amplified using the same primers ." ], "offsets": [ [ 0, 140 ] ] } ]
[ { "id": "split_0_train_46126_entity", "type": "progene_text", "text": [ "dioxygenase" ], "offsets": [ [ 4, 15 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28486
split_0_train_28486
[ { "id": "split_0_train_28486_passage", "type": "progene_text", "text": [ "Target and competitor sequences had identical amplification kinetics ." ], "offsets": [ [ 0, 70 ] ] } ]
[]
[]
[]
[]
split_0_train_28487
split_0_train_28487
[ { "id": "split_0_train_28487_passage", "type": "progene_text", "text": [ "Potential PCR inhibitors that could coextract with DNA , nonamplifying DNA , soil factors ( humics ) , and soil pollutants ( toluene ) did not impact enumeration ." ], "offsets": [ [ 0, 163 ] ] } ]
[]
[]
[]
[]
split_0_train_28488
split_0_train_28488
[ { "id": "split_0_train_28488_passage", "type": "progene_text", "text": [ "Therefore , this technique can be used to accurately and reproducibly quantify catechol 2 , 3-dioxygenase genes in complex environments such as petroleum - contaminated soil ." ], "offsets": [ [ 0, 175 ] ] } ]
[ { "id": "split_0_train_46127_entity", "type": "progene_text", "text": [ "catechol 2 , 3-dioxygenase" ], "offsets": [ [ 79, 105 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28489
split_0_train_28489
[ { "id": "split_0_train_28489_passage", "type": "progene_text", "text": [ "Direct , non - cultivation - based molecular techniques for detecting and enumerating microbial pollutant - biodegrading genes in environmental samples are powerful tools for monitoring bioremediation and developing field evidence in support of natural attenuation ." ], "offsets": [ [ 0, 266 ] ] } ]
[]
[]
[]
[]
split_0_train_28490
split_0_train_28490
[ { "id": "split_0_train_28490_passage", "type": "progene_text", "text": [ "Steroid dehydrogenase structures , mechanism of action , and disease ." ], "offsets": [ [ 0, 70 ] ] } ]
[ { "id": "split_0_train_46128_entity", "type": "progene_text", "text": [ "Steroid dehydrogenase" ], "offsets": [ [ 0, 21 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28491
split_0_train_28491
[ { "id": "split_0_train_28491_passage", "type": "progene_text", "text": [ "Steroid dehydrogenase enzymes influence mammalian reproduction , hypertension , neoplasia , and digestion ." ], "offsets": [ [ 0, 107 ] ] } ]
[ { "id": "split_0_train_46129_entity", "type": "progene_text", "text": [ "Steroid dehydrogenase" ], "offsets": [ [ 0, 21 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28492
split_0_train_28492
[ { "id": "split_0_train_28492_passage", "type": "progene_text", "text": [ "The three - dimensional structures of steroid dehydrogenase enzymes reveal the position of the catalytic triad , a possible mechanism of keto - hydroxyl interconversion , a molecular mechanism of inhibition , and the basis for selectivity ." ], "offsets": [ [ 0, 240 ] ] } ]
[ { "id": "split_0_train_46130_entity", "type": "progene_text", "text": [ "steroid dehydrogenase" ], "offsets": [ [ 38, 59 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28493
split_0_train_28493
[ { "id": "split_0_train_28493_passage", "type": "progene_text", "text": [ "Glycyrrhizic acid , the active ingredient in licorice , and its metabolite carbenoxolone are potent inhibitors of human 11 beta-hydroxysteroid dehydrogenase and bacterial 3 alpha , 20 beta-hydroxysteroid dehydrogenase ( 3 alpha , 20 beta-HSD ) ." ], "offsets": [ [ 0, 245 ] ] } ]
[ { "id": "split_0_train_46131_entity", "type": "progene_text", "text": [ "11 beta-hydroxysteroid dehydrogenase" ], "offsets": [ [ 120, 156 ] ], "normalized": [] }, { "id": "split_0_train_46132_entity", "type": "progene_text", "text": [ "3 alpha , 20 beta-hydroxysteroid dehydrogenase" ], "offsets": [ [ 171, 217 ] ], "normalized": [] }, { "id": "split_0_train_46133_entity", "type": "progene_text", "text": [ "3 alpha , 20 beta-HSD" ], "offsets": [ [ 220, 241 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28494
split_0_train_28494
[ { "id": "split_0_train_28494_passage", "type": "progene_text", "text": [ "The three - dimensional structure of the 3 alpha , 20 beta-HSD carbenoxolone complex unequivocally verifies the postulated active site of the enzyme , shows that inhibition is a result of direct competition with the substrate for binding , and provides a plausible model for the mechanism of inhibition of 11 beta-hydroxysteroid dehydrogenase by carbenoxolone ." ], "offsets": [ [ 0, 361 ] ] } ]
[ { "id": "split_0_train_46134_entity", "type": "progene_text", "text": [ "3 alpha , 20 beta-HSD" ], "offsets": [ [ 41, 62 ] ], "normalized": [] }, { "id": "split_0_train_46135_entity", "type": "progene_text", "text": [ "11 beta-hydroxysteroid dehydrogenase" ], "offsets": [ [ 306, 342 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28495
split_0_train_28495
[ { "id": "split_0_train_28495_passage", "type": "progene_text", "text": [ "The structure of the ternary complex of human 17 beta-hydroxysteroid dehydrogenase type 1 ( 17 beta-HSD ) with the cofactor NADP + and the antiestrogen equilin reveals the details of binding of an inhibitor in the active site of the enzyme and the possible roles of various amino acids in the catalytic cleft ." ], "offsets": [ [ 0, 310 ] ] } ]
[ { "id": "split_0_train_46136_entity", "type": "progene_text", "text": [ "17 beta-hydroxysteroid dehydrogenase type 1" ], "offsets": [ [ 46, 89 ] ], "normalized": [] }, { "id": "split_0_train_46137_entity", "type": "progene_text", "text": [ "17 beta-HSD" ], "offsets": [ [ 92, 103 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28496
split_0_train_28496
[ { "id": "split_0_train_28496_passage", "type": "progene_text", "text": [ "The short - chain dehydrogenase reductase ( SDR ) family includes these steroid dehydrogenase enzymes and more than 60 other proteins from human , mammalian , insect , and bacterial sources ." ], "offsets": [ [ 0, 191 ] ] } ]
[ { "id": "split_0_train_46138_entity", "type": "progene_text", "text": [ "short - chain dehydrogenase reductase ( SDR ) family" ], "offsets": [ [ 4, 56 ] ], "normalized": [] }, { "id": "split_0_train_46139_entity", "type": "progene_text", "text": [ "steroid dehydrogenase" ], "offsets": [ [ 72, 93 ] ], "normalized": [] } ]
[]
[]
[]
split_0_train_28497
split_0_train_28497
[ { "id": "split_0_train_28497_passage", "type": "progene_text", "text": [ "Most members of the family contain the tyrosine and lysine of the catalytic triad in a YxxxK sequence ." ], "offsets": [ [ 0, 103 ] ] } ]
[]
[]
[]
[]
split_0_train_28498
split_0_train_28498
[ { "id": "split_0_train_28498_passage", "type": "progene_text", "text": [ "X-ray crystal structures of 13 members of the family have been completed ." ], "offsets": [ [ 0, 74 ] ] } ]
[]
[]
[]
[]
split_0_train_28499
split_0_train_28499
[ { "id": "split_0_train_28499_passage", "type": "progene_text", "text": [ "When the alpha-carbon backbone of the cofactor binding domains of the structures are superimposed , the conserved residues are at the core of the structure and in the cofactor binding domain , but not in the substrate binding pocket ." ], "offsets": [ [ 0, 234 ] ] } ]
[]
[]
[]
[]